AP Healthcare

KOSDAQ-109960
KOSDAQ
Drugs, Drug Proprietaries, and Druggists' Sundries
Global Rank
#29918
Country Rank
#1740
Market Cap
48.2 M
Price
0.244
Change (%)
2.15%
Volume
520,850

AP Healthcare's latest marketcap:

48.2 M

As of 06/27/2025, AP Healthcare's market capitalization has reached $48.2 M. According to our data, AP Healthcare is the 29918th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 48.2 M
Revenue (ttm) 11.96 M
Net Income (ttm) -56,149,839.59
Shares Out 200.75 M
EPS (ttm) -0.41
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/12/2025
Market Cap Chart
Data Updated: 06/27/2025

AP Healthcare's yearly market capitalization.

AP Healthcare has seen its market value drop from ₩8.32 B to ₩48.2 M since 2014, representing a total decrease of 99.42% and an annual compound decline rate (CAGR) of 38.80%.
Date Market Cap Change (%) Global Rank
06/27/2025 ₩48.2 M -37.43% 29918
12/30/2024 ₩104.59 B 102.9% 25651
12/28/2023 ₩51.55 B -23.01% 29341
12/29/2022 ₩66.95 B -46.5% 26470
12/30/2021 ₩125.15 B -5.53% 22803
12/30/2020 ₩132.47 B -10.6% 19463
12/30/2019 ₩148.18 B 12.93% 16887
12/28/2018 ₩131.22 B -19.33% 16470
12/28/2017 ₩162.67 B 39.18% 15920
12/29/2016 ₩116.87 B 11.22% 16132

Company Profile

About AP Healthcare Inc.

AP Healthcare Inc. is a pharmaceutical distributor based in South Korea, specializing in the supply of prescription and over-the-counter medications. The company serves healthcare providers and consumers with a diverse range of medical products.

Product Offerings

  • Prescription medications (antibiotics, antifungal agents, antiviral drugs)
  • Infusion solutions & peptic ulcer treatments
  • Osteoarthritis therapies & brain function improvement agents
  • Respiratory solvents & topical medicines
  • Adrenocorticosteroids & urinary medicines
  • Hair loss treatments & antipyretic analgesics
  • Antihistamines & obesity agents
  • Neural contract solutions & liver extracts
  • Fire extinguisher solvents

Company Background

Founded in 1998 and headquartered in Seongnam-si, South Korea, the company was formerly known as Aprogen Healthcare & Games Inc. before rebranding to AP Healthcare Inc. in April 2024.

Frequently Asked Questions

  • What is AP Healthcare's (KOSDAQ-109960) current market cap?
    As of 06/27/2025, AP Healthcare (including the parent company, if applicable) has an estimated market capitalization of $48.2 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • AP Healthcare global market capitalization ranking is approximately 29918 as of 06/27/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.